Quarraisha A. Karim
Affiliations: | Columbia University, New York, NY |
Area:
Public HealthGoogle:
"Quarraisha Karim"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mahomed S, Bukusi E, Sikazwe I, et al. (2024) A risk- and needs-based strategy HIV prevention for adolescent girls and young women, WHO African Region. Bulletin of the World Health Organization. 102: 913-915 |
| Karim F, Riou C, Bernstein M, et al. (2024) Clearance of persistent SARS-CoV-2 associates with increased neutralizing antibodies in advanced HIV disease post-ART initiation. Nature Communications. 15: 2360 |
| Mahomed S, Garrett N, Potloane D, et al. (2023) Extended safety and tolerability of subcutaneous CAP256V2LS and VRC07-523LS in HIV-negative women: study protocol for the randomised, placebo-controlled double-blinded, phase 2 CAPRISA 012C trial. Bmj Open. 13: e076843 |
| Collins C, Isbell MT, Karim QA, et al. (2023) Leveraging the HIV response to strengthen pandemic preparedness. Plos Global Public Health. 3: e0001511 |
| Karim QA, Archary D, Barré-Sinoussi F, et al. (2022) Women for science and science for women: Gaps, challenges and opportunities towards optimizing pre-exposure prophylaxis for HIV-1 prevention. Frontiers in Immunology. 13: 1055042 |
| Humphries H, Lewis L, Lamontagne E, et al. (2022) Impact of COVID-19 public health responses on income, food security and health services among key and vulnerable women in South Africa. African Journal of Aids Research : Ajar. 21: 317-329 |
| Molatlhegi RP, Ngcobo S, Liebenberg LJP, et al. (2021) Genital and systemic immune effects of the injectable, contraceptive norethisterone enanthate (NET-EN), in South African women. American Journal of Reproductive Immunology (New York, N.Y. : 1989). e13411 |
| Mahomed S, Garrett N, Karim QA, et al. (2020) Assessing the safety and pharmacokinetics of the anti-HIV monoclonal antibody CAP256V2LS alone and in combination with VRC07-523LS and PGT121 in South African women: study protocol for the first-in-human CAPRISA 012B phase I clinical trial. Bmj Open. 10: e042247 |
| Karim QA, Karim SSA. (2020) COVID-19 affects HIV and tuberculosis care. Science. 369: 366-368 |
| Karim QA, Havlir D, Phanuphak N. (2020) Putting women in the centre of the global HIV response is key to achieving epidemic control Journal of the International Aids Society. 23 |